| Literature DB >> 33911546 |
Weon Ju Lee1, Dong Hyuk Eun1, Seok Min Kim1, Jun Young Kim1, Yong Hyun Jang1, Seok-Jong Lee1.
Abstract
Entities:
Year: 2019 PMID: 33911546 PMCID: PMC7992692 DOI: 10.5021/ad.2019.31.1.84
Source DB: PubMed Journal: Ann Dermatol ISSN: 1013-9087 Impact factor: 1.444
Fig. 1(A) Cell Counting Kit-8 (CCK8) assay at different concentrations of alpha-lipoic acid. (B) Protein expression of inflammatory biomarkers in cultured human sebocytes after treatment with 50 µM of alpha-lipoic acid (lipoic acid) and/or 10−7 M of dihydrotestosterone (DHT) on the enzyme-linked immunosorbent assay (ELISA). (C) Protein expression of inflammatory biomarkers in cultured human sebocytes after treatment with 50 µM of alpha-lipoic acid (lipoic acid) and/or 5 µg of lipopolysaccharide (LPS) on the ELISA. IL: interleukin, TNF: tumor necrosis factor. *p<0.05.
Fig. 2(A) Sebum production in cultured human sebocytes after treatment with 50 µM of alpha-lipoic acid (lipoic acid) and/or 10−7 M of dihydrotestosterone (DHT). (B) Lipid peroxidation in cultured human sebocytes after treatment with 50 µM of alpha-lipoic acid (lipoic acid) and/or 10−7 M of DHT. (C) Lipid peroxidation in cultured human sebocytes after treatment with 50 µM of alpha-lipoic acid (lipoic acid) and/or 5 µg of lipopolysaccharide (LPS).